Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression

References

Ahmed, D., Eide, P.W., Eilertsen, I.A., Danielsen, S.A., Eknaes, M., Hektoen, M., Lind, G.E., and Lothe, R.A. (2013). Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis 2, e71.10.1038/oncsis.2013.35Search in Google Scholar PubMed PubMed Central

Akcakaya, H., Aroymak, A., and Gokce, S. (2007). A. quantitative colorimetric method of measuring alkaline phosphatase activity in eukaryotic cell membranes. Cell. Biol. Int. 31, 186–190.10.1016/j.cellbi.2006.11.014Search in Google Scholar PubMed

Alison, M.R., Lin, W.R., Lim, S.M., and Nicholson, L.J. (2012). Cancer stem cells: in the line of fire. Cancer Treat. Rev. 38, 589–598.10.1016/j.ctrv.2012.03.003Search in Google Scholar PubMed

Bates, R.C. and Mercurio, A.M. (2005). The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol. Ther. 4, 365–370.10.4161/cbt.4.4.1655Search in Google Scholar PubMed

Beck, S.E., Jung, B.H., Fiorino, A., Gomez, J., Rosario, E.D., Cabrera, B.L., Huang, S.C., Chow, J.Y., and Carethers, J.M. (2006). Bone morphogenetic protein signaling and growth suppression in colon cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G135–G145.10.1152/ajpgi.00482.2005Search in Google Scholar PubMed PubMed Central

Beck, S.E., Jung, B.H., Del Rosario, E., Gomez, J., and Carethers, J.M. (2007). BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK. Cell Signal. 19, 1465–1472.10.1016/j.cellsig.2007.01.017Search in Google Scholar PubMed PubMed Central

Beites, C.L., Hollenbeck, P.L., Kim, J., Lovell-Badge, R., Lander, A.D., and Calof, A.L. (2009). Follistatin modulates a BMP autoregulatory loop to control the size and patterning of sensory domains in the developing tongue. Development 136, 2187–2197.10.1242/dev.030544Search in Google Scholar PubMed PubMed Central

Bendtsen, J.D., Jensen, L.J., Blom, N., Von Heijne, G., and Brunak, S. (2004). Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 17, 349–356.10.1093/protein/gzh037Search in Google Scholar PubMed

Beppu, H., Mwizerwa, O.N., Beppu, Y., Dattwyler, M.P., Lauwers, G.Y., Bloch, K.D., and Goldstein, A.M. (2008). Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation. Oncogene 27, 1063–1070.10.1038/sj.onc.1210720Search in Google Scholar PubMed

Bertrand, F.E., Angus, C.W., Partis, W.J., and Sigounas, G. (2012). Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch. Cell Cycle 11, 4344–4351.10.4161/cc.22134Search in Google Scholar PubMed PubMed Central

Bhowmick, N.A. and Moses, H.L. (2005). Tumor-stroma interactions. Curr. Opin. Genet. Dev. 15, 97–101.10.1016/j.gde.2004.12.003Search in Google Scholar PubMed PubMed Central

Bissell, M.J. and Radisky, D. (2001). Putting tumours in context. Nat. Rev. Cancer 1, 46–54.10.1038/35094059Search in Google Scholar PubMed PubMed Central

Boland, C.R. and Goel, A. (2010). Microsatellite instability in colorectal cancer. Gastroenterology 138, 2073–2087 e3.10.1053/j.gastro.2009.12.064Search in Google Scholar PubMed PubMed Central

Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., and Kirchner, T. (2005). Opinion: migrating cancer stem cells – an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744–749.10.1038/nrc1694Search in Google Scholar PubMed

Cai, Z.G., Zhang, S.M., Zhang, H., Zhou, Y.Y., Wu, H.B., and Xu, X.P. (2013). Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line. Cell. Biol. Int. 37, 669–674.10.1002/cbin.10087Search in Google Scholar PubMed

Chen, D., Zhao, M., and Mundy, G.R. (2004). Bone morphogenetic proteins. Growth Factors 22, 233–241.10.1080/08977190412331279890Search in Google Scholar PubMed

Chen, M.H., Yeh, Y.C., Shyr, Y.M., Jan, Y.H., Chao, Y., Li, C.P., Wang, S.E., Tzeng, C.H., Chang, P.M., Liu, C.Y., et al. (2012). Expression of gremlin 1 correlates with increased angiogenesis and progression-free survival in patients with pancreatic neuroendocrine tumors. J. Gastroenterol. 48, 101–108.10.1007/s00535-012-0614-zSearch in Google Scholar PubMed

Collier, T.S., Randall, S.M., Sarkar, P., Rao, B.M., Dean, R.A., and Muddiman, D.C. (2011). Comparison of stable-isotope labeling with amino acids in cell culture and spectral counting for relative quantification of protein expression. Rapid Commun. Mass Spectrom. 25, 2524–2532.10.1002/rcm.5151Search in Google Scholar PubMed

De Wever, O., Pauwels, P., De Craene, B., Sabbah, M., Emami, S., Redeuilh, G., Gespach, C., Bracke, M., and Berx, G. (2008). Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem. Cell Biol. 130, 481–494.10.1007/s00418-008-0464-1Search in Google Scholar PubMed PubMed Central

Deng, H., Makizumi, R., Ravikumar, T.S., Dong, H., Yang, W., and Yang, W.L. (2007a). Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells. Exp. Cell Res. 313, 1033–1044.10.1016/j.yexcr.2006.12.020Search in Google Scholar PubMed

Deng, H., Ravikumar, T.S., and Yang, W.L. (2007b). Bone morphogenetic protein-4 inhibits heat-induced apoptosis by modulating MAPK pathways in human colon cancer HCT116 cells. Cancer Lett. 256, 207–217.10.1016/j.canlet.2007.06.008Search in Google Scholar PubMed

Deng, H., Ravikumar, T.S., and Yang, W.L. (2009). Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells. Cancer Lett. 281, 220–231.10.1016/j.canlet.2009.02.046Search in Google Scholar PubMed

Elenbaas, B. and Weinberg, R.A. (2001). Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264, 169–184.10.1006/excr.2000.5133Search in Google Scholar PubMed

Gazzerro, E. and Canalis, E. (2006). Bone morphogenetic proteins and their antagonists. Rev. Endocr. Metab. Disord. 7, 51–65.10.1007/s11154-006-9000-6Search in Google Scholar PubMed

Goswami, C.P. and Nakshatri, H. (2013). PROGgene: gene expression based survival analysis web application for multiple cancers. J. Clin. Bioinforma 3, 22.10.1186/2043-9113-3-22Search in Google Scholar PubMed PubMed Central

Grijelmo, C., Rodrigue, C., Svrcek, M., Bruyneel, E., Hendrix, A., de Wever, O., and Gespach, C. (2007). Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent signaling pathways in colon cancer cells. Cell Signal. 19, 1722–1732.10.1016/j.cellsig.2007.03.008Search in Google Scholar PubMed

Hanahan, D. and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646–674.10.1016/j.cell.2011.02.013Search in Google Scholar PubMed

Hardwick, J.C., Van Den Brink, G.R., Bleuming, S.A., Ballester, I., Van Den Brande, J.M., Keller, J.J., Offerhaus, G.J., Van Deventer, S.J., and Peppelenbosch, M.P. (2004). Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology 126, 111–121.10.1053/j.gastro.2003.10.067Search in Google Scholar PubMed

Hardwick, J.C., Kodach, L.L., Offerhaus, G.J., and van den Brink, G.R. (2008). Bone morphogenetic protein signalling in colorectal cancer. Nat. Rev. Cancer 8, 806–812.10.1038/nrc2467Search in Google Scholar PubMed

He, X.C., Zhang, J., Tong, W.G., Tawfik, O., Ross, J., Scoville, D.H., Tian, Q., Zeng, X., He, X., Wiedemann, L.M., et al. (2004). BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nat. Genet. 36, 1117–1121.10.1038/ng1430Search in Google Scholar PubMed

Hirakawa, M., Takimoto, R., Tamura, F., Yoshida, M., Ono, M., Murase, K., Sato, Y., Osuga, T., Sato, T., Iyama, S., et al. (2013). Fucosylated TGF-beta receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells. Br. J. Cancer 110, 156–163.10.1038/bjc.2013.699Search in Google Scholar

Ilyas, M., Straub, J., Tomlinson, I.P., and Bodmer, W.F. (1999). Genetic pathways in colorectal and other cancers. Eur. J. Cancer 35, 335–351.10.1016/S0959-8049(98)00431-6Search in Google Scholar

Ishizuya-Oka, A. (2005). Epithelial-connective tissue cross-talk is essential for regeneration of intestinal epithelium. J. Nippon Med. Sch. 72, 13–18.10.1272/jnms.72.13Search in Google Scholar PubMed

Jain, K.K. (2008). Innovations, challenges and future prospects of oncoproteomics. Mol. Oncol. 2, 153–160.10.1016/j.molonc.2008.05.003Search in Google Scholar PubMed PubMed Central

Kalluri, R. (2009). EMT: when epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest. 119, 1417–1419.10.1172/JCI39675Search in Google Scholar PubMed PubMed Central

Kalluri, R. and Weinberg, R.A. (2009). The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420–1428.10.1172/JCI39104Search in Google Scholar PubMed PubMed Central

Kang, M.H., Kang, H.N., Kim, J.L., Kim, J.S., Oh, S.C., and Yoo, Y.A. (2009). Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion. Oncol. Rep. 22, 525–534.Search in Google Scholar

Karagiannis, G.S., Pavlou, M.P., and Diamandis, E.P. (2010). Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Mol. Oncol. 4, 496–510.10.1016/j.molonc.2010.09.001Search in Google Scholar PubMed PubMed Central

Karagiannis, G.S., Petraki, C., Prassas, I., Saraon, P., Musrap, N., Dimitromanolakis, A., and Diamandis, E.P. (2012a). Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis. Oncotarget 3, 267–285.10.18632/oncotarget.451Search in Google Scholar PubMed PubMed Central

Karagiannis, G.S., Poutahidis, T., Erdman, S.E., Kirsch, R., Riddell, R.H., and Diamandis, E.P. (2012b). Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Mol. Cancer Res. 10, 1403–1418.10.1158/1541-7786.MCR-12-0307Search in Google Scholar PubMed PubMed Central

Karagiannis, G.S., Berk, A., Dimitromanolakis, A., and Diamandis, E.P. (2013). Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1. Mol. Oncol. 7, 826–839.10.1016/j.molonc.2013.04.002Search in Google Scholar PubMed PubMed Central

Karagiannis, G.S., Schaeffer, D.F., Cho, C.K., Musrap, N., Saraon, P., Batruch, I., Grin, A., Mitrovic, B., Kirsch, R., Riddell, R.H., et al. (2014a). Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin. Mol. Oncol. 8, 178–195.10.1016/j.molonc.2013.10.008Search in Google Scholar PubMed PubMed Central

Karagiannis, G.S., Pavlou, M.P., Saraon, P., Musrap, N., Xie, A., Batruch, I., Prassas, I., Dimitromanolakis, A., Petraki, C., and Diamandis, E.P. (2014b). In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers. J. Proteomics 103, 121–136.10.1016/j.jprot.2014.03.018Search in Google Scholar PubMed

Karagiannis, G.S., Treacy, A., Messenger, D., Grin, A., Kirsch, R., Riddell, R.H., and Diamandis, E,P. (2014c) Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts. Mol. Oncol., in press.10.1016/j.molonc.2014.04.004Search in Google Scholar PubMed PubMed Central

Khokha, M.K., Hsu, D., Brunet, L.J., Dionne, M.S., and Harland, R.M. (2003). Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat. Genet. 34, 303–307.10.1038/ng1178Search in Google Scholar PubMed

Kishigami, S. and Mishina, Y. (2005). BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev. 16, 265–278.10.1016/j.cytogfr.2005.04.002Search in Google Scholar PubMed

Kodach, L.L., Bleuming, S.A., Musler, A.R., Peppelenbosch, M.P., Hommes, D.W., van den Brink, G.R., van Noesel, C.J., Offerhaus, G.J., and Hardwick, J.C. (2008). The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer. Cancer 112, 300–306.10.1002/cncr.23160Search in Google Scholar PubMed

Kosinski, C., Li, V.S., Chan, A.S., Zhang, J., Ho, C., Tsui, W.Y., Chan, T.L., Mifflin, R.C., Powell, D.W., Yuen, S.T., et al. (2007). Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc. Natl. Acad. Sci. USA 104, 15418–15423.10.1073/pnas.0707210104Search in Google Scholar PubMed PubMed Central

Kukko, H.M., Koljonen, V.S., Tukiainen, E.J., Haglund, C.H., and Bohling, T.O. (2010). Vascular invasion is an early event in pathogenesis of Merkel cell carcinoma. Mod. Pathol. 23, 1151–1156.10.1038/modpathol.2010.100Search in Google Scholar PubMed

Kulasingam, V. and Diamandis, E.P. (2008). Tissue culture-based breast cancer biomarker discovery platform. Int. J. Cancer 123, 2007–2012.10.1002/ijc.23844Search in Google Scholar PubMed

Kunz-Schughart, L.A. and Knuechel, R. (2002a). Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression? Histol. Histopathol. 17, 599–621.Search in Google Scholar

Kunz-Schughart, L.A. and Knuechel, R. (2002b). Tumor-associated fibroblasts (part II): Functional impact on tumor tissue. Histol. Histopathol. 17, 623–637.Search in Google Scholar

Lappin, D.W., McMahon, R., Murphy, M., and Brady, H.R. (2002). Gremlin: an example of the re-emergence of developmental programmes in diabetic nephropathy. Nephrol. Dial. Transplant 17 (Suppl 9), 65–67.10.1093/ndt/17.suppl_9.65Search in Google Scholar PubMed

Li, Y., Zhu, X., Zeng, Y., Wang, J., Zhang, X., Ding, Y.Q., and Liang, L. (2010). FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition. Mol. Cancer Res. 8, 1579–1590.10.1158/1541-7786.MCR-10-0081Search in Google Scholar PubMed

Loboda, A., Nebozhyn, M.V., Watters, J.W., Buser, C.A., Shaw, P.M., Huang, P.S., Van’t Veer, L., Tollenaar, R.A., Jackson, D.B., Agrawal, D., et al. (2011). EMT is the dominant program in human colon cancer. BMC Med. Genomics 4, 9.10.1186/1755-8794-4-9Search in Google Scholar PubMed PubMed Central

Lorente-Trigos, A., Varnat, F., Melotti, A., and Ruiz i Altaba, A. (2010). BMP signaling promotes the growth of primary human colon carcinomas in vivo. J. Mol. Cell. Biol. 2, 318–332.10.1093/jmcb/mjq035Search in Google Scholar PubMed

Markowitz, S.D. and Bertagnolli, M.M. (2009). Molecular origins of cancer: Molecular basis of colorectal cancer. N. Engl. J. Med. 361, 2449–2460.10.1056/NEJMra0804588Search in Google Scholar PubMed PubMed Central

Mezzano, S., Droguett, A., Burgos, M.E., Aros, C., Ardiles, L., Flores, C., Carpio, D., Carvajal, G., Ruiz-Ortega, M., and Egido, J. (2007). Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis. Nephrol. Dial. Transplant. 22, 1882–1890.10.1093/ndt/gfm145Search in Google Scholar PubMed

Michos, O., Panman, L., Vintersten, K., Beier, K., Zeller, R., and Zuniga, A. (2004). Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 131, 3401–3410.10.1242/dev.01251Search in Google Scholar PubMed

Michos, O., Goncalves, A., Lopez-Rios, J., Tiecke, E., Naillat, F., Beier, K., Galli, A., Vainio, S., and Zeller, R. (2007). Reduction of BMP4 activity by gremlin 1 enables ureteric bud outgrowth and GDNF/WNT11 feedback signalling during kidney branching morphogenesis. Development 134, 2397–2405.10.1242/dev.02861Search in Google Scholar PubMed

Mitola, S., Ravelli, C., Moroni, E., Salvi, V., Leali, D., Ballmer-Hofer, K., Zammataro, L., and Presta, M. (2010). Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2. Blood 116, 3677–3680.10.1182/blood-2010-06-291930Search in Google Scholar PubMed

Mitrovic, B., Schaeffer, D.F., Riddell, R.H., and Kirsch, R. (2012). Tumor budding in colorectal carcinoma: time to take notice. Mod. Pathol. 25, 1315–1325.10.1038/modpathol.2012.94Search in Google Scholar PubMed

Miyazono, K., Maeda, S., and Imamura, T. (2005). BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16, 251–263.10.1016/j.cytogfr.2005.01.009Search in Google Scholar PubMed

Motoyama, K., Tanaka, F., Kosaka, Y., Mimori, K., Uetake, H., Inoue, H., Sugihara, K., and Mori, M. (2008). Clinical significance of BMP7 in human colorectal cancer. Ann. Surg. Oncol. 15, 1530–1537.10.1245/s10434-007-9746-4Search in Google Scholar PubMed

Mulvihill, M.S., Kwon, Y.W., Lee, S., Fang, L.T., Choi, H., Ray, R., Kang, H.C., Mao, J.H., Jablons, D., and Kim, I.J. (2012). Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells. PLoS One 7, e42264.10.1371/journal.pone.0042264Search in Google Scholar PubMed PubMed Central

Murphy, M., McMahon, R., Lappin, D.W., and Brady, H.R. (2002). Gremlins: is this what renal fibrogenesis has come to? Exp. Nephrol. 10, 241–244.10.1159/000063698Search in Google Scholar PubMed

Myllärniemi, M., Lindholm, P., Ryynanen, M.J., Kliment, C.R., Salmenkivi, K., Keski-Oja, J., Kinnula, V.L., Oury, T.D., and Koli, K. (2008). Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 177, 321–329.10.1164/rccm.200706-945OCSearch in Google Scholar PubMed PubMed Central

Navab, R., Strumpf, D., Bandarchi, B., Zhu, C.Q., Pintilie, M., Ramnarine, V.R., Ibrahimov, E., Radulovich, N., Leung, L., Barczyk, M., et al. (2011). Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc. Natl. Acad. Sci. USA 108, 7160–7165.10.1073/pnas.1014506108Search in Google Scholar PubMed PubMed Central

Nishanian, T.G., Kim, J.S., Foxworth, A., and Waldman, T. (2004). Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells. Cancer Biol. Ther. 3, 667–675.10.4161/cbt.3.7.965Search in Google Scholar PubMed

Orimo, A., Gupta, P.B., Sgroi, D.C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V.J., Richardson, A.L., and Weinberg, R.A. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335–348.10.1016/j.cell.2005.02.034Search in Google Scholar PubMed

Owens, P., Pickup, M.W., Novitskiy, S.V., Chytil, A., Gorska, A.E., Aakre, M.E., West, J., and Moses, H.L. (2011) Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators. Proc. Natl. Acad. Sci. USA 109, 2814–2819.10.1073/pnas.1101139108Search in Google Scholar PubMed PubMed Central

Owens, P., Polikowsky, H., Pickup, M.W., Gorska, A.E., Jovanovic, B., Shaw, A.K., Novitskiy, S.V., Hong, C.C., and Moses, H.L. (2013). Bone Morphogenetic Proteins stimulate mammary fibroblasts to promote mammary carcinoma cell invasion. PLoS One 8, e67533.10.1371/journal.pone.0067533Search in Google Scholar PubMed PubMed Central

Ravelli, C., Mitola, S., Corsini, M., and Presta, M. (2012). Involvement of alphavbeta3 integrin in gremlin-induced angiogenesis. Angiogenesis 16, 235–243.10.1007/s10456-012-9309-6Search in Google Scholar PubMed

Rooijens, P.P., de Krijger, R.R., Bonjer, H.J., van der Ham, F., Nigg, A.L., Bruining, H.A., Lamberts, S.W., and van der Harst, E. (2004). The significance of angiogenesis in malignant pheochromocytomas. Endocr. Pathol. 15, 39–45.10.1385/EP:15:1:39Search in Google Scholar

Roxburgh, S.A., Kattla, J.J., Curran, S.P., O’Meara, Y.M., Pollock, C.A., Goldschmeding, R., Godson, C., Martin, F., and Brazil, D.P. (2009). Allelic depletion of grem1 attenuates diabetic kidney disease. Diabetes 58, 1641–1650.10.2337/db08-1365Search in Google Scholar

Sääf, A.M., Halbleib, J.M., Chen, X., Yuen, S.T., Leung, S.Y., Nelson, W.J., and Brown, P.O. (2007). Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in <softenter;normal colon and colon cancer. Mol. Biol. Cell 18, 4245–4260.10.1091/mbc.e07-04-0309Search in Google Scholar

Saraon, P., Musrap, N., Cretu, D., Karagiannis, G.S., Batruch, I., Smith, C., Drabovich, A.P., Trudel, D., van der Kwast, T., Morrissey, C., et al. (2012). Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein, S. during the development of high grade and castration-resistant prostate cancer. J. Biol. Chem. 287, 34019–34031.10.1074/jbc.M112.384438Search in Google Scholar

Saraon, P., Cretu, D., Musrap, N., Karagiannis, G.S., Batruch, I., Drabovich, A.P., van der Kwast, T., Mizokami, A., Morrissey, C., Jarvi, K., et al. (2013). Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression. Mol. Cell Proteomics 12, 1589–1601.10.1074/mcp.M112.023887Search in Google Scholar

Scheel, C. and Weinberg, R.A. (2012). Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 22, 396–403.10.1016/j.semcancer.2012.04.001Search in Google Scholar

Sell, S. (2010). On the stem cell origin of cancer. Am. J. Pathol 176, 2584–494.10.2353/ajpath.2010.091064Search in Google Scholar

Shen, L., Qu, X., Ma, Y., Zheng, J., Chu, D., Liu, B., Li, X., Wang, M., Xu, C., Liu, N., et al. (2014). Tumor suppressor NDRG2 tips the balance of oncogenic TGF-beta via EMT inhibition in colorectal cancer. Oncogenesis 3, e86.10.1038/oncsis.2013.48Search in Google Scholar

Slattery, M.L., Lundgreen, A., Herrick, J.S., Kadlubar, S., Caan, B.J., Potter, J.D., and Wolff, R.K. (2011a). Genetic variation in bone morphogenetic protein and colon and rectal cancer. Int. J. Cancer 130, 653–664.10.1002/ijc.26047Search in Google Scholar

Slattery, M.L., Lundgreen, A., Herrick, J.S., Wolff, R.K., and Caan, B.J. (2011b). Genetic variation in the transforming growth factor-beta signaling pathway and survival after diagnosis with colon and rectal cancer. Cancer 117, 4175–4183.10.1002/cncr.26018Search in Google Scholar

Smith, J.J., Deane, N.G., Wu, F., Merchant, N.B., Zhang, B., Jiang, A., Lu, P., Johnson, J.C., Schmidt, C., Bailey, C.E., et al. (2009). Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138, 958–968.10.1053/j.gastro.2009.11.005Search in Google Scholar

Sneddon, J.B. (2009). The contribution of niche-derived factors to the regulation of cancer cells. Methods Mol. Biol. 568, 217–232.10.1007/978-1-59745-280-9_14Search in Google Scholar

Sneddon, J.B. and Werb, Z. (2007). Location, location, location: the cancer stem cell niche. Cell Stem Cell 1, 607–611.10.1016/j.stem.2007.11.009Search in Google Scholar

Sneddon, J.B., Zhen, H.H., Montgomery, K., van de Rijn, M., Tward, A.D., West, R., Gladstone, H., Chang, H.Y., Morganroth, G.S., Oro, A.E., et al. (2006). Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc. Natl. Acad. Sci. USA 103, 14842–14847.10.1073/pnas.0606857103Search in Google Scholar

Souvannavong, V., Lemaire, C., De Nay, D., Brown, S., and Adam, A. (1995). Expression of alkaline phosphatase by a B-cell hybridoma and its modulation during cell growth and apoptosis. Immunol. Lett. 47, 163–170.10.1016/0165-2478(95)00075-7Search in Google Scholar

Spaderna, S., Schmalhofer, O., Hlubek, F., Jung, A., Kirchner, T., and Brabletz, T. (2007). Epithelial-mesenchymal and mesenchymal-epithelial transitions during cancer progression. Verh. Dtsch. Ges. Pathol. 91, 21–28.Search in Google Scholar

Stabile, H., Mitola, S., Moroni, E., Belleri, M., Nicoli, S., Coltrini, D., Peri, F., Pessi, A., Orsatti, L., Talamo, F., et al. (2007). Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood 109, 1834–1840.10.1182/blood-2006-06-032276Search in Google Scholar

Sugino, T., Kusakabe, T., Hoshi, N., Yamaguchi, T., Kawaguchi, T., Goodison, S., Sekimata, M., Homma, Y., and Suzuki, T. (2002). An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. Am. J. Pathol. 160, 1973–1980.10.1016/S0002-9440(10)61147-9Search in Google Scholar

Sugino, T., Yamaguchi, T., Ogura, G., Saito, A., Hashimoto, T., Hoshi, N., Yoshida, S., Goodison, S., and Suzuki, T. (2004). Morphological evidence for an invasion-independent metastasis pathway exists in multiple human cancers. BMC Med. 2, 9.10.1186/1741-7015-2-9Search in Google Scholar PubMed PubMed Central

Tse, J.C. and Kalluri, R. (2007). Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J. Cell. Biochem. 101, 816–829.10.1002/jcb.21215Search in Google Scholar PubMed

von Bubnoff, A. and Cho, K.W. (2001). Intracellular BMP signaling regulation in vertebrates: pathway or network? Dev. Biol. 239, 1–14.10.1006/dbio.2001.0388Search in Google Scholar PubMed

von Kleist, S., Chany, E., Burtin, P., King, M., and Fogh, J. (1975). Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor. J. Natl. Cancer Inst. 55, 555–560.10.1093/jnci/55.3.555Search in Google Scholar PubMed

Watnick, R.S. (2012). The role of the tumor microenvironment in regulating angiogenesis. Cold Spring Harb. Perspect. Med. 2, a006676.10.1101/cshperspect.a006676Search in Google Scholar PubMed PubMed Central

Weiss, L. and Ward, P.M. (1983). Cell detachment and metastasis. Cancer Metastasis Rev. 2, 111–127.10.1007/BF00048965Search in Google Scholar PubMed

Werfel, J., Krause, S., Bischof, A.G., Mannix, R.J., Tobin, H., Bar-Yam, Y., Bellin, R.M., and Ingber, D.E. (2013). How changes in extracellular matrix mechanics and gene expression variability might combine to drive cancer progression. PLoS One 8, e76122.10.1371/journal.pone.0076122Search in Google Scholar PubMed PubMed Central

Wu, W.K., Sung, J.J., Wu, Y.C., Li, Z.J., Yu, L., and Cho, C.H. (2008). Bone morphogenetic protein signalling is required for the anti-mitogenic effect of the proteasome inhibitor MG-132 on colon cancer cells. Br. J. Pharmacol. 154, 632–638.10.1038/bjp.2008.115Search in Google Scholar PubMed PubMed Central

Xu, R.H., Peck, R.M., Li, D.S., Feng, X., Ludwig, T., and Thomson, J.A. (2005). Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human, E.S. cells. Nat. Methods 2, 185–190.10.1038/nmeth744Search in Google Scholar PubMed

Yan, K., Wu, Q., Yan, D.H., Lee, C.H., Rahim, N., Tritschler, I., DeVecchio, J., Kalady, M.F., Hjelmeland, A.B., Rich, J.N. (2014). Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy. Genes Dev. 28, 1085–1100.10.1101/gad.235515.113Search in Google Scholar PubMed PubMed Central

Zeisberg, E.M., Potenta, S., Xie, L., Zeisberg, M., and Kalluri, R. (2007). Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 67, 10123–10128.10.1158/0008-5472.CAN-07-3127Search in Google Scholar PubMed

Zhang, J.F., Fu, W.M., He, M.L., Xie, W.D., Lv, Q., Wan, G., Li, G., Wang, H., Lu, G., Hu, X., et al. (2011). MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol. 8, 829–838.10.4161/rna.8.5.16043Search in Google Scholar PubMed

Zlobec, I. and Lugli, A. (2011). Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget 1, 651–661.10.18632/oncotarget.199Search in Google Scholar PubMed PubMed Central